Wilson Sonsini advised Chroma Medicine on the deal.Genomic medicine company Chroma Medicine announced that it had completed a $135 million Series B financing, which was led…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
